Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
Abstract
Abstract. Scientists proposed that curcumin could be used for treatment of non-alcoholic fatty liver disease (NAFLD). In this article, we aimed to identify the effect of curcumin on NAFLD improvement. Fifty patients with NAFLD, were divided into two groups in this randomized, double-blind, and controlled clinical trial. Patients in the curcumin group received 250 mg/day of phytosomal curcumin, while those in the control group received 250 mg/day of placebo for duration of eight weeks. Anthropometric measurements and fasting blood samples were taken once at the baseline and once at the end of the study. Analysis was performed on 45 patients (curcumin group n = 22, placebo group n = 22). According to between groups analysis, curcumin significantly reduced the carboxymethyl lisine (CML) (148 ± 108 ng/mL vs 197 ± 101 ng/mL, P = 0.04), 8-hydroxy-2’ -deoxyguanosine (8-OHdG) (46.9 ± 31.1 ng/mL vs 52.1 ± 43.1 ng/mL P = 0.03), liver enzymes (P < 0.001), weight (P < 0.001), waist circumference (P < 0.001), body fat percent (P < 0.01), and body mass index (BMI) (P < 0.01) in comparison with placebo. However, curcumin supplementation compared to placebo did not reduce soluble receptors for advanced glycation end products (sRAGE), hip circumference, waist/hip, and fat free mass by the end of the study. Our study indicated that phytosamal curcumin might be able to reduce the NAFLD progress by reducing the anthropometric measures, AGEs, and DNA damage. However, we need more studies with longer intervention duration, and larger sample size.
References
1 (2002) Nonalcoholic fatty liver disease. N Engl J Med. 346, 1221–31.
2 (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 42, 132–8.
3 (2013) How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease? Hepat Mon. 13, e15227.
4 (2010) Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition (Burbank, Los Angeles County, Calif). 26, 1094–9.
5 (2011) Reactive oxygen species in the normal and acutely injured liver. Journal of Hepatology. 55, 227–8.
6 (2013) Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. J Clin Exp Hepatol. 3, 12–8.
7 (2010) Maillard reaction, mitochondria and oxidative stress: potential role of antioxidants. Pathol Biol. 58, 220–5.
8 (2001) Biochemistry and molecular cell biology of diabetic complications. Nature. 414, 813–20.
9 (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J. 375, 581–92.
10 (2012) Effect of dietary advanced glycation end products on mouse liver. PLoS One. 7, e35143.
11 (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS journal. 15, 195–218.
12 (2018) Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother Res: PTR.
13 (2005) Therapeutic potential of curcumin in non-alcoholic steatohepatitis. Nutr Res Rev. 18, 212–21.
14 (2019) Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents. Crit Rev Food Sci Nutr. 59, 1169–77.
15 (2016) Curcumin inhibits advanced glycation end product-induced oxidative stress and inflammatory responses in endothelial cell damage via trapping methylglyoxal. Mol Med Rep. 13, 1475–86.
16 (2017) Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System. Curr Pharm Des. 23, 1135–41.
17 (2018) Liposomal Curcumin Attenuates the Incidence of Oxidative Stress, Inflammation, and DNA Damage Induced by Copper Sulfate in Rat Liver. Dose-response. 16, 1559325818790869.
18 (2019) In vitro investigation of the effects of boron nitride nanotubes and curcumin on DNA damage. Daru. 27, 203–18.
19 (2007) Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 60, 171–7.
20 (2011) Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 74, 664–9.
21 (2015) A randomized, double-blind, placebo-controlled, clinical trial on probiotic soy milk and soy milk: effects on epigenetics and oxidative stress in patients with type II diabetes. Genes Nutr. 10, 52.
22 (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 35, 1381–95.
23 (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 371, 887–95.
24 (2007) The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin. Basic Clin Pharmacol Toxicol. 101, 411–5.
25 (2018) Pre and post treatment with curcumin and resveratrol protects astrocytes after oxidative stress. Brain Res. 1692, 45–55.
26 (2018) Curcumin protects heart tissue against irinotecan-induced damage in terms of cytokine level alterations, oxidative stress, and histological damage in rats. Naunyn Schmiedebergs Arch Pharmacol.
27 (2018) Curcumin nanomicelle improves semen parameters, oxidative stress, inflammatory biomarkers, and reproductive hormones in infertile men: A randomized clinical trial. Phytother Res. 32, 514–21.
28 (2012) Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 11, 79.
29 (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol. 29, 642–51.
30 (2019) Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Gastrointestin Liver Dis: JGLD. 28, 183–9.
31 (2009) 8-hydroxy-2’ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C. 27, 120–39.
32 (2016) Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes. Nutrients. 8
33 (2012) Trapping of methylglyoxal by curcumin in cell-free systems and in human umbilical vein endothelial cells. J Agric Food Chem. 60, 8190–6.
34 (2008) Free radical generation by methylglyoxal in tissues. Drug Metabol Drug Interact. 23, 151–73.
35 (2008) Inhibitory effect of vanillic acid on methylglyoxal-mediated glycation in apoptotic Neuro-2A cells. Neurotoxicology. 29, 1016–22.
36 (2017) Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents. Crit Rev Food Sci Nutr. 1–9.
37 (2013) Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. Int J Mol Sci. 14, 19846–66.
38 (2009) Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin Biochem. 42, 802–7.
39 (2015) Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study. Eur Rev Med Pharmacol Sci. 19, 4195–202.
40 (2015) Curcumin Mimics the Neurocognitive and Anti-Inflammatory Effects of Caloric Restriction in a Mouse Model of Midlife Obesity. PloS one. 10, e0140431.
41 (2013) Curcumin and obesity. BioFactors (Oxford, England). 39, 78–87.
42 (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. 139, 919–25.
43 (2009) Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J Agric Food Chem. 57, 305–10.
44 (2018) Effect of Curcumin on Anthropometric Measures: A Systematic Review on Randomized Clinical Trials. J Am Coll Nutr. 37, 215–22.
45 (2019) The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials. Pharm Pract. 17, 1350.
46 (2019) Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur J Nutr.